Stage III Pancreatic Cancer AJCC v8 trials recruiting in California

All Stage III Pancreatic Cancer AJCC v8 trials nationally

Cities in California

Recruiting trials in California

• A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
  NCT06906562 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Fresno, Los Angeles, San Diego, San Francisco
• AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
  NCT07619313 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
  NCT06454383 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte
• Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
  NCT06998940 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Arroyo Grande, Auburn, Berkeley, Burbank
• TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
  NCT07189195 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Sacramento
• Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
  NCT06958328 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Arroyo Grande, Bakersfield, Berkeley, Burlingame
• Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
  NCT04172532 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Irvine, Orange, Sacramento
• Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
  NCT05372614 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · California: Duarte, Irvine, Lancaster, Orange